-
公开(公告)号:US20070197590A1
公开(公告)日:2007-08-23
申请号:US11669284
申请日:2007-01-31
申请人: Duane DeMong , Mingde Xia , Scott Pollack , Xiaoping Zheng , James Brackley , Michael Wachter , Druie Cavender , Keith Demarest
发明人: Duane DeMong , Mingde Xia , Scott Pollack , Xiaoping Zheng , James Brackley , Michael Wachter , Druie Cavender , Keith Demarest
IPC分类号: A61K31/4545 , C07D401/14
CPC分类号: C07D401/14 , C07D211/26 , C07D211/48 , C07D405/14 , C07D471/04
摘要: Substituted dipiperidine compounds of Formula (I) or a form thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
摘要翻译: 式(I)的取代二哌啶化合物或其形式,其是CCR2拮抗剂,并且可用于预防,治疗或改善有需要的受试者中CCR2介导的炎性综合征,病症或疾病。
-
公开(公告)号:US20060069123A1
公开(公告)日:2006-03-30
申请号:US11224215
申请日:2005-09-12
申请人: Mingde Xia , Michael Wachter , Meng Pan , Duane DeMong , Scott Pollack
发明人: Mingde Xia , Michael Wachter , Meng Pan , Duane DeMong , Scott Pollack
IPC分类号: A61K31/4545 , C07D403/14
CPC分类号: C07D401/06 , A61K31/4545 , A61K45/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D417/14 , C07D471/04 , C07D491/04 , A61K2300/00
摘要: Substituted dipiperidine compounds of Formula (I) or a salt, isomer, prodrug, metabolite or polymorph thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
摘要翻译: 式(I)的取代二哌啶化合物
-
公开(公告)号:US20060089378A1
公开(公告)日:2006-04-27
申请号:US11253127
申请日:2005-10-18
申请人: Mingde Xia , Meng Pan , Michael Wachter , Fina Liotta
发明人: Mingde Xia , Meng Pan , Michael Wachter , Fina Liotta
IPC分类号: A61K31/4745 , C07D471/02 , A61K31/56 , A61K31/55 , A61K31/19 , A61K31/195
CPC分类号: C07D471/04
摘要: This invention is directed to a tetrahydro-pyridinyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢 - 吡啶基吡唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20070259853A1
公开(公告)日:2007-11-08
申请号:US11691713
申请日:2007-03-27
申请人: Mingde Xia , Fina Liotta , Michael Wachter
发明人: Mingde Xia , Fina Liotta , Michael Wachter
IPC分类号: A61K31/55 , A61P25/08 , C07D223/14
CPC分类号: C07D487/04
摘要: This invention is directed to a tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢-1H-1,2,6-三氮杂 - 薁类大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20050228034A1
公开(公告)日:2005-10-13
申请号:US11087943
申请日:2005-03-23
申请人: Bharat Lagu , Fina Liotta , Meng Pan , Michael Wachter , Mingde Xia
发明人: Bharat Lagu , Fina Liotta , Meng Pan , Michael Wachter , Mingde Xia
IPC分类号: A61K31/416 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/06 , C07D409/06 , C07D409/12 , C07D451/02 , C07D453/02
CPC分类号: C07D231/56 , C07D401/12 , C07D403/12 , C07D405/06 , C07D409/06 , C07D409/12 , C07D451/02 , C07D453/02
摘要: This invention is directed to a tetrahydro-indazole cannabinoid modulator compound of formula I: and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式I的四氢 - 吲唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20080058313A1
公开(公告)日:2008-03-06
申请号:US11674210
申请日:2007-02-13
申请人: Fina Liotta , Huajun Lu , Michael Wachter , Mingde Xia
发明人: Fina Liotta , Huajun Lu , Michael Wachter , Mingde Xia
IPC分类号: C07D231/56 , A61K31/416 , A61K31/445 , A61K31/55 , C07D401/02 , C07D403/02 , A61P1/00 , A61P25/00 , A61P3/00
CPC分类号: C07D409/04 , C07D231/56 , C07D403/12
摘要: This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula (I): or a form thereof, wherein p, R1, R2 and Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢-2H-吲唑吡唑大麻素调节剂化合物或其形式,其中p,R 1,R 2和Ar 如本文所述,*表示手性中心,以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20060223798A1
公开(公告)日:2006-10-05
申请号:US11376844
申请日:2006-03-16
申请人: Fina Liotta , Huajun Lu , Mingde Xia , Michael Wachter
发明人: Fina Liotta , Huajun Lu , Mingde Xia , Michael Wachter
IPC分类号: A61K31/5377 , A61K31/454 , A61K31/4162 , C07D498/02
CPC分类号: C07D495/04
摘要: The invention relates to a CB modulator compound of Formula (I) or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.
-
公开(公告)号:US20080085899A1
公开(公告)日:2008-04-10
申请号:US11952375
申请日:2007-12-07
申请人: Fina Liotta , Huajun Lu , Mingde Xia , Michael Wachter
发明人: Fina Liotta , Huajun Lu , Mingde Xia , Michael Wachter
IPC分类号: A61K31/415 , A61K31/44 , A61K31/535 , A61P43/00 , C07D211/32 , C07D231/54 , C07D401/00 , C07D413/00
CPC分类号: C07D495/04
摘要: The invention relates to a CB modulator compound of Formula (I) or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的CB调节剂化合物或其药学上可接受的形式,以及用于治疗,改善或预防CB受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20070254911A1
公开(公告)日:2007-11-01
申请号:US11690429
申请日:2007-03-23
申请人: Mingde Xia , Meng Pan , Fina Liotta , Michael Wachter
发明人: Mingde Xia , Meng Pan , Fina Liotta , Michael Wachter
IPC分类号: A61K31/4745 , C07D471/02
CPC分类号: C07D471/04
摘要: This invention is directed to a tetrahydro-pyrazolo[3,4-c]pyridine cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢 - 吡唑并[3,4-c]吡啶大麻素调节剂化合物:和用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20070191362A1
公开(公告)日:2007-08-16
申请号:US11525572
申请日:2006-09-22
申请人: Fina Liotta , Mingde Xia , Michael Wachter , Scott Beers
发明人: Fina Liotta , Mingde Xia , Michael Wachter , Scott Beers
IPC分类号: A61K31/5377 , A61K31/496 , A61K31/454 , A61K31/416 , C07D413/02 , C07D403/02
CPC分类号: C07D231/54
摘要: This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢 - 环戊基吡唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
-
-
-
-
-
-
-
-